- Company is almost debt free.
- Company has delivered good profit growth of 35.0%
CAGR over last 5 years
- Dividend Yield 1.12 %
- PE 8 vs Industry PE of 29
Albert David Ltd is engaged in manufacturing and trading of Pharmaceutical Formulations, Infusion Solutions, Herbal Dosage Forms and Bulk Drugs by way of domestic sale or export.
During FY22, the Co. introduced two products i.e., Evacure and C3H in the market. It is expected that these two products will augment the revenue and profits of the Company.
The Co. will continue to focus on enhancing its presence organically as well as inorganically, both in the domestic and the international market.
- Company has delivered good profit growth of 35.0%
CAGR over last 5 years
- Dividend Yield 1.12 %
- PE 8 vs Industry PE of 29
Albert David Ltd is engaged in manufacturing and trading of Pharmaceutical Formulations, Infusion Solutions, Herbal Dosage Forms and Bulk Drugs by way of domestic sale or export.
During FY22, the Co. introduced two products i.e., Evacure and C3H in the market. It is expected that these two products will augment the revenue and profits of the Company.
The Co. will continue to focus on enhancing its presence organically as well as inorganically, both in the domestic and the international market.
*DISCLAIMER*
For educational purposes only. Not a recommendation.
Treat StopLoss as your best friend to get you out of troubles.
For educational purposes only. Not a recommendation.
Treat StopLoss as your best friend to get you out of troubles.